The Lung Cancer Awareness Month Coalition

is a group of leading international research and advocacy organizations that partner each November in an effort to improve outcomes for lung cancer patients across the world. Unlike many other diseases, with lung cancer, there is a shocking lack of knowledge among both patients and physicians about effective risk reduction and treatment options. The Coalition seeks to fill this void, inspiring hope and achieving better results for patients in the process. Most of all, the Coalition strives to debunk the unfair assumptions and stigma associated with lung cancer by better educating the public on the disease and its causes.




Epidermal growth factor receptor (EGFR) mutations occur in 10 to 20 percent of NSCLC tumors1, and as high as 60 percent in NSCLC tumors in Asian populations.2 Lung Cancer Survivor, Joan Fong, is alive today because of advances in the identification and treatment of lung cancer, in particular, because of targeted oral therapy that was determined very effective for her particular tumor mutation.


Over the last 39 years, the rate of new lung cancer cases has fallen 32% among men while increasing 94% among women. Since the peak rate for men in 1984, the rate of new cases for men has dropped 41%. Since the peak rate of new cases for women in 1998, the rate of new cases for women has fallen 10%.3 Dusty Donaldson, is an 11-year survivor, whose symptoms led her to a diagnosis of stage 1b NSCLC adenocarcinoma. Dusty is alive because the cancer was detected early and eliminated through surgery and chemotherapy. She is still cancer free today.


The FDA approved the first personalized medicine for certain epidermal growth factor receptor (EGFR) mutation-positive metastatic NSCLC in the USA in May of 2013. The drug is called erlotinib, and it was approved for initial (first-line) treatment of people with NSCLC whose tumors have been identified to have certain EGFR mutations by an FDA approved test. A 39 year old lung cancer survivor and mother of four, Jill Feldman, was diagnosed with the EGFR mutation and began receiving personalized treatment.


Figure Bodybuilder Fights Lung Cancer

In the spring of 2014, I started having trouble with my shoulder that included some muscle atrophy and nerve pain. My physical therapist, John Graham, PT, suggested something bigger was going on and worried I might have a tumor somewhere in my right upper chest. He suggested I get a chest X-ray and an ultrasound of my lymph nodes. I thought he was crazy. I felt great and was back to training hard for a figure bodybuilding competition.

Lung Cancer Knows No Age.

(Mike’s story is told by his mom.)  My name is Susan. I am a mom of 2 beautiful sons, Michael and Chris. I’m a wife, and my husband is a medical researcher. I’m a registered nurse. I’m an artist. I have a wonderful daughter-in-law Michele, and 4 amazing grandchildren. Mike called me on a Sunday morning with a complaint of chest pain. He thought it was likely a pulled muscle from playing sports and horsing around with his children. He was specific about the location of the pain (right upper chest) and said activity did not make it worse. He had no cough. He had no fever. He had no other symptoms. I advised him to see his doctor asap. What followed seems unreal.

Three Years and Thriving with ALK Positive Lung Cancer.

Our journey with lung cancer began in November 2013. My husband, Jeff, had run his fourth half marathon that fall, and I was carrying our baby. I was in my second trimester. He felt great and looked good. Jeff had no symptoms that raised a red flag that something was seriously wrong with him. Earlier that spring he had been sick for about a week, nothing severe; he didn’t even take a sick day from work. Since the spring he had a cough that lingered for a while. Eventually, it would show up only when he was laughing hard or sometimes when he got out of the shower in the morning.

© 2017 by SQUAWKDOG